SCHEDULE 13G/A: BlackRock Amends Stake in Progyny, Inc., Disclosing 13.0% Passive Ownership
Ownership Disclosure
BlackRock, Inc. has filed an amendment to its Schedule 13G, reaffirming its passive beneficial ownership of 13.0% of Progyny, Inc.'s common stock as of March 31, 2025.
Summary
- BlackRock, Inc. filed an Amendment No. 4 to its Schedule 13G regarding its beneficial ownership in Progyny, Inc.
- As of March 31, 2025, BlackRock, Inc. beneficially owns an aggregate of 11,153,242 shares of Progyny, Inc. Common Stock.
- This ownership represents 13.0% of the class of securities.
- BlackRock holds sole voting power over 11,069,383 shares and sole dispositive power over 11,153,242 shares.
- No shared voting or dispositive power is reported.
- The filing indicates that the securities were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing the control of Progyny, Inc.
- iShares Core S&P Small-Cap ETF, a BlackRock entity, is noted as having an interest of more than five percent of the total outstanding common stock.
Sentiment
Score: 5
Explanation: The document is a factual, routine regulatory filing (Schedule 13G/A) disclosing passive ownership. It contains no forward-looking statements, performance metrics, or strategic updates from the issuer, thus maintaining a neutral sentiment.
Future Outlook
NA
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
Industry Context
This filing is a routine disclosure of a significant passive ownership stake by a major institutional investor, BlackRock, in Progyny, Inc. It does not provide specific insights into broader industry trends or competitive dynamics beyond confirming BlackRock's continued investment in the company.
Key Dates
| Date | Description |
|---|---|
| 2025-01-21 | Date of execution of the Power of Attorney by BlackRock, Inc. |
| 2025-03-31 | Date of event which requires the filing of this statement (end of reporting period). |
| 2025-04-28 | Date of signature for the Schedule 13G/A filing. |
Keywords
BlackRock, Progyny Inc, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Investment Management, Passive Investment, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.